John Cones Email & Phone Number

Charlotte, NC, US

San Rafael, CA, US

• In this role, I was recruited by senior executives to start-up the hemophilia gene therapy team. This role has been focused on building an Account Team business model, requiring strategic steps towards developing.
• Leading launch of ROCTAVIAN, the first gene therapy for hemophilia A in a competitive space; utilizing a buy-and-bill model for a $2.9M product.
• Directing a team of 22 Account Managers responsible for promotion of ROCTAVIAN to HCPs in 145 Hemophilia Treatment Centers (HTCs) and to patients in 68 regional advocacy organizations.
• Leading the Advocacy and Field Reimbursement function during the initial phases of launch.
• Initiating and successfully managing the BioMarin’s relationship with Hemophilia Alliance GPO, which was pivotal in obtaining a contractual agreement with over 110 Hemophilia Treatment Centers (HTCs).

San Rafael, CA, US

• In my third position within BioMarin, I successfully led a sales team of 21 individuals for the promotion of KUVAN, an enzyme chaperone therapy and PALYNQIZ, an enzyme substitution therapy for patient with.
• Launched PALYNZIQ, surpassing the revenue goal by 25% for 2018 and exceeding all KPIs.
• Consistently exceeded KUVAN revenue goals, representing over 30% of global revenue.
• Garnered stakeholder support and executive alignment for a changed incentive compensation plan that provided new opportunities and focus for the sales team.
• Partnered with Marketing, Clinical Coordinators, and HUB leadership to optimize customer service, supporting prescribers, genetic clinics, and patients.

San Rafael, CA, US

• As I progressed through ranks within BioMarin, I earned recognition after 18 months as an outstanding leader and was promoted to Senior Director (NSD) for the Neuromuscular Franchise.
• Formed a 25-person sales team for the launch of drisapersen, an antisense oligonucleotide designed for exon skipping in Duchenne Muscular Dystrophy (DMD), a rare pediatric genetic neuromuscular disorder.
• Deployed account managers to survey stakeholders in the Ped Neurology space and worked with cross-functional departments to ensure launch readiness.
• BioMarin elected to retain 19 of 25 employees after the Complete Response Letter from the FDA; redeployed those employees to other franchises.

San Rafael, CA, US

• In my initial role with BioMarin, I evaluated an dprovided recommendations for improvement within the western region of the United States, working closely with new Account Managers and assisting others as they departed.
• Created and maintained a strong relationship with the East Region Director, developing a cohesive team approach across the country with both internal and external stakeholders.
• Redesigned the IC plan to improve fairness and equitability across all territories.

• As the Director of Sales, I partnered with the VP of Commercial to cultivate and launch a sales strategy and team for the Winx Sleep Therapy System, an innovative medical device for obstructive sleep apnea.
• Established key relationships with opinion leaders and provided product access and support for sleep specialists throughout the eastern half of the United States.
• Hired multiple Territory Managers and began a controlled launch of the Winx device to test the market space and to better understand market opportunities and threats.
• Gained expertise in device sales, including the areas of manufacturing, distribution, marketing, sales, reimbursement services, and customer service functions.

Charlotte, NC, US

• While working with Chelsea Therapeutics, I ensured this start-up company was ready to dploy a top-tier sales team of 100 employees for the launch of Northera, a pioneering druge for neurogenic orthostatic hypotension.
• Analyzed sales models and determined moving forward with an internal sales organization optimized resources and created more synergy within the company.
• Leveraged strategic vendors to execute operational tasks while retaining control, presenting and gaining approval from the Board of Directors.
• Identified and contracted with 12+ sales operations vendors, recruited and hired a team of 10 Regional Directors and a Director of Training, and ensured all partners were best-in-class.

New Brunswick, NJ, US

• In this position, I directed the performance of all J&J pharmaceutical products in the institutional channel, focused on GPOs, major IDNs, Vas, and the Department of Defense.
• Co-led and mentored a new team of 14 Institutional National Account Directors (NADs) from the large and small molecule businesses. IDN coverage accounted for 70% of J&J business in the institutional channel.
• Delivered input on pricing and contracting strategies that impacted gross-to-net revenue.

New Brunswick, NJ, US

• While serving in this role, I led the integration of Scios and Ortho-McNeil Institutional to establish a new institutional cardiovascular franchise at Ortho-McNeil. During my tenure, I development deployment schemas.
• Directed and guided a 220-person sales team of Regional Business Directors, District Managers, Regional Trainers, and Cardiovascular Specialists.
• Exceeded market share goal by 40% with orthopedic surgeons after the launch of NUCYNTA.

Master Of Business Administration - Mba

Bachelor Of Science (B.S.)